TAS-106 is a new nucleoside antimetabolite. TAS-106 has demonstrated strong antitumor activity without serious toxicity in nude rat models bearing human tumours .
Investigated for use/treatment in solid tumors and cancer/tumors (unspecified).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.